Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
14
GBX
Market Cap:
£17.5m
Income Statement
Earnings Waterfall
Fusion Antibodies PLC
Fusion Antibodies PLC
Income Statement
Fusion Antibodies PLC
Fusion Antibodies PLC
Currency: GBP
| Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
3
N/A
|
2
-28%
|
2
+13%
|
3
+50%
|
4
+19%
|
4
+4%
|
4
+3%
|
5
+13%
|
5
+2%
|
4
-12%
|
3
-31%
|
2
-46%
|
1
-28%
|
2
+59%
|
2
+9%
|
2
-19%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(1)
|
|
| Gross Profit |
1
N/A
|
1
-47%
|
1
+3%
|
1
+78%
|
2
+24%
|
2
+8%
|
2
+6%
|
2
+16%
|
2
+5%
|
2
-24%
|
1
-69%
|
(0)
N/A
|
(0)
+62%
|
0
N/A
|
0
+18%
|
0
-18%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Selling, General & Administrative |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
0
N/A
|
(1)
N/A
|
(2)
-4%
|
(1)
+18%
|
(1)
+14%
|
(1)
+5%
|
(1)
-24%
|
(1)
-7%
|
(1)
+1%
|
(2)
-46%
|
(3)
-48%
|
(3)
-6%
|
(2)
+24%
|
(2)
+27%
|
(2)
-7%
|
(2)
+14%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
|
| Non-Reccuring Items |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
-104%
|
(1)
-4%
|
(1)
+18%
|
(1)
+13%
|
(1)
+5%
|
(1)
-23%
|
(1)
-6%
|
(1)
+1%
|
(2)
-46%
|
(3)
-47%
|
(3)
-6%
|
(2)
+24%
|
(2)
+27%
|
(2)
-7%
|
(2)
+14%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
-82%
|
(1)
+1%
|
(1)
+21%
|
(1)
+30%
|
(1)
+0%
|
(3)
-317%
|
(3)
-4%
|
(1)
+60%
|
(2)
-44%
|
(3)
-50%
|
(3)
-9%
|
(2)
+22%
|
(2)
+27%
|
(2)
-5%
|
(1)
+14%
|
|
| EPS (Diluted) |
-0.04
N/A
|
-0.05
-25%
|
-0.06
-20%
|
-0.05
+17%
|
-0.03
+40%
|
-0.03
N/A
|
-0.11
-267%
|
-0.12
-9%
|
-0.05
+58%
|
-0.07
-40%
|
-0.1
-43%
|
-0.06
+40%
|
-0.04
+33%
|
-0.02
+50%
|
-0.02
N/A
|
-0.01
+50%
|
|
Switch to:
Switch to:
See Also
Discover More
